Two specific weather patterns have been identified as capable of increasing the risk of headaches, thanks to physicians at the University of Cincinnati College of Medicine, along with researchers at the Icahn School of Medicine ...
Jun 4, 2026
0
23
Fremanezumab yields a greater reduction in the number of migraine days and headache days than placebo among children and adolescents with episodic migraine, according to a study published in the Jan. 15 issue of the New England ...
Jan 20, 2026
0
10
The U.S. Food and Drug Administration has approved the single-dose Ajovy (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in children and adolescents.
Aug 11, 2025
0
16
Albert Einstein College of Medicine and Teva Pharmaceuticals, in collaboration with multiple international institutions, report findings on the efficacy of fremanezumab (sold as Ajovy by Teva) in reducing migraine frequency ...
As temperatures rise, so do chances for migraine attacks, according to a new study from a team of researchers at the University of Cincinnati College of Medicine, Icahn School of Medicine at Mount Sinai, Errex Inc. and Teva ...
Jun 14, 2024
0
67
